Exciting news! Ascendia Pharmaceutical Solutions is heading to the 2025 Bio CEO & Investor Conference in New York, taking place February 10-11, 2025. As one of the largest investor conferences in the biotech industry, this event gathers institutional investors, industry analysts, and senior executives who are shaping the future of pharmaceutical innovation and investment.
We are thrilled to announce that Jim Huang, Ph.D. (CEO) and Robert Bloder (CBO) will be representing Ascendia Pharmaceutical Solutions as sponsors of this premier event.
With extensive experience in pharmaceutical R&D, formulation development, and business strategy, Jim and Bob are eager to engage with investors, biotech and pharma companies, and other industry leaders to discuss potential partnerships, funding opportunities, and the latest advancements in drug formulation and manufacturing.
Ascendia will be participating in BIO Partnering™ during the CEO & Investor Conference for one-on-one meetings. They are also available for separate meetings at the Marriott Marquis, a venue offering an ideal setting to connect with new and existing clients and discuss the Ascendia Difference—our innovative approach to solving complex drug development challenges. Our meeting slots are filling up fast, so if you're interested in discussing how we can ensure your drug formulation and manufacturing project stays on schedule and within budget, be sure to schedule a time with us as soon as possible!
Ascendia is more than a Contract Development and Manufacturing Organization (CDMO); we are a solutions-driven partner for biopharma companies tackling the most complex formulation and manufacturing challenges. We specialize in:
- Advanced Nanotechnology Approaches – Enhancing solubility and bioavailability using micro/nano-emulsions, nanoparticles, LNPs, and amorphous solid dispersions.
- Innovative Drug Delivery Solutions – Expertise in oral, injectable, and transmucosal/topical formulations.
- State-of-the-Art Manufacturing – As the only North American CDMO with the DeltaVita® Netzsch Mill, , our large-scale nano-suspension manufacturing capabilities are unmatched.
- Rapid Project Kickoff – We can initiate projects within two weeks of contract signing, ensuring your drug development timeline stays on track.
One key highlight we will be discussing at the Bio CEO & Investor Conference is Ascendia’s recent rebranding from Ascendia Pharmaceuticals to Ascendia Pharmaceutical Solutions. This transformation reflects our growth from a formulation development company to a comprehensive solutions provider, offering end-to-end services from early-stage development to commercial-scale manufacturing.
In 2024, we made major advancements in our technology platforms and manufacturing infrastructure, including:
- Expansion of our sterile aseptic manufacturing capabilities.
- Investment in cutting-edge nano-suspension production equipment.
- Increased focus on long-acting injectables, lipid nanoparticles (LNPs), and other nanotechnologies.
With 2024 bringing significant shifts in the biotech and pharmaceutical landscape, including increased demand for domestic U.S.-based manufacturing and development, Ascendia Pharmaceutical Solutions is strategically positioned to be the partner of choice for pharma and biotech companies looking for reliable, high-quality solutions.
As a company with a long history of participating in BIO events, we understand the value of one-on-one discussions at conferences like these. Whether you're a startup looking for an experienced CDMO, an established pharmaceutical company exploring new formulation approaches, or an investor seeking the next big opportunity in drug development, Ascendia is ready to collaborate with you.
Don’t miss your chance to connect with Jim Huang and Bob Bloder at the BIO CEO & Investor Conference. If you’re attending and want to explore how Ascendia can help bring your next drug to market, reach out now to schedule a meeting.
We look forward to seeing you in New York City and discussing how Ascendia Pharmaceutical Solutions can accelerate your drug development journey!
Schedule your meeting today - https://calendly.com/jared-hahn/2025-bio-ceo